relife to life. 3. The first quantitative model for the accumulation of driver and passenger mutations in cancer progression (in collaboration with Bert Vogelstein). 4. The fundamental laws that determine how population structure affect evolutionary dynamics. 5. A new theory for the emergence of advanced soci

I am also working on evolutionary processes in medicine such as the dynamics of virus infections and cancer. I have an excellent collaboration with Bert Vogelstein, who is one of the leading cancer biologists in the world. Many years ago my calculations helped to obtain a quantitative understanding of HIV infe

nce itself. This piece focuses on his work on eusociality in ants and prelife. (I could easily write a short follow-up piece on his cancer work with Bert Vogelstein, particularly once their forthcoming paper is published in Nature.) > All this to say that I'm not married to this format. What I've written is lon

FR TK inhibitors became resistant from a single mutation of the protein T790M within the EGFR kinase domain. PED's work caught the attention of Dr. Bert Vogelstein, the Director of the Ludwig Center for Cancer Genetics and Therapeutics at the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University

lar and cellular behavior with the precision of an engineer and share those findings with physicians." In that same year 2010, the PED presented to Bert Vogelstein, professor and director of the Ludwig Center for Cancer Genetics and Therapeutics at the Johns Hopkins Kimmel Cancer Center and the Howard Hughes M

lar and cellular behavior with the precision of an engineer and share those findings with physicians." In that same year 2010, the PED presented to Bert Vogelstein, professor and director of the Ludwig Center for Cancer Genetics and Therapeutics at the Johns Hopkins Kimmel Cancer Center and the Howard Hughes M

nce itself. This piece focuses on his work on =usociality in ants and prelife. (I could easily write a short follow-up =iece on his cancer work with Bert Vogelstein, particularly once their =orthcoming paper is published in Nature.) All this to say that ='m not married to this format. What I've written is long a

nce itself. This piece focuses o= his work on eusociality in ants and prelife. (I could easily write a short=follow-up piece on his cancer work with Bert Vogelstein, particularly once t=eir forthcoming paper is published in Nature.) <=pan>AII this to say that I'm not married to this format. What I've written i=

ER TX inhibitors became resistant from a single mutation of the protein T790M within the EGER kinase domain. PED's work caught the attention of Ile. Bert Vogelstein, the lYinzetor of the Ludwig Center for Cancer Genetics and 'Therapeutics at the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Universi

ER TX inhibitors became resistant from a single mutation of the protein T790M within the EGER kinase domain. PED's work caught the attention of Ile. Bert Vogelstein, the lYinzetor of the Ludwig Center for Cancer Genetics and 'Therapeutics at the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Universi